1
|
Piguet C, Klauser P, Celen Z, James Murray R, Magnus Smith M, Merglen A. Randomized controlled trial of a mindfulness-based intervention in adolescents from the general population: The Mindfulteen neuroimaging study protocol. Early Interv Psychiatry 2022; 16:891-901. [PMID: 34734463 PMCID: PMC9539898 DOI: 10.1111/eip.13235] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Revised: 09/08/2021] [Accepted: 10/19/2021] [Indexed: 11/26/2022]
Abstract
AIM Adolescence is a period of vulnerability to stress. Increased anxiety during this period has been associated with the later development of mental disorders, hence the growing interest for interventions that could decrease stress reactivity and improve cognitive control in adolescents. Mindfulness-based interventions have demonstrated their efficacy on stress reactivity and anxiety in adults, but evidence is lacking in youth. METHODS The Mindfulteen Study is a 3-year longitudinal cohort with a nested randomized controlled trial examining the effectiveness of mindfulness-based interventions for adolescents. Young adolescents from the general population, aged between 13 and 15 years old, with no history of current mental health disorder (apart from past mood disorders or current anxiety disorders) are included and stratified into low or high anxiety based on trait anxiety scores before being randomized to early or late 8-week intervention groups. Primary outcomes are based on neuroimaging data (i.e., structural and functional measures in the cortico-limbic network) while secondary outcomes are psychological (i.e., anxiety and stress-associated dimensions) and biological (i.e., cortisol, inflammatory and redox markers). Assessments are performed at baseline, immediately after intervention or waiting time and after 18 months of intervention. CONCLUSION To the best of our knowledge, this is the first randomized controlled trail examining the effect of a mindfulness-based intervention in young adolescents from the general population based on the measurement and analyses of psychological, neuroimaging and biological data.
Collapse
Affiliation(s)
- Camille Piguet
- Child and Adolescent Psychiatry Division, Geneva University Hospitals, Geneva, Switzerland.,Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Paul Klauser
- Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.,Service of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland
| | - Zeynep Celen
- Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Ryan James Murray
- Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Mariana Magnus Smith
- Division of General Pediatrics, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Arnaud Merglen
- Division of General Pediatrics, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Geneva, Switzerland
| |
Collapse
|
2
|
Bègue I, Blakemore R, Klug J, Cojan Y, Galli S, Berney A, Aybek S, Vuilleumier P. Metacognition of visuomotor decisions in conversion disorder. Neuropsychologia 2018; 114:251-265. [PMID: 29698734 DOI: 10.1016/j.neuropsychologia.2018.04.018] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Revised: 04/19/2018] [Accepted: 04/20/2018] [Indexed: 12/21/2022]
Abstract
Motor conversion disorder (CD) entails genuine disturbances in the subjective experience of patients who maintain they are unable to perform a motor function, despite lack of apparent neurological damage. Abilities by which individuals assess their own capacities during performance in a task are called metacognitive, and distinctive impairment of such abilities is observed in several disorders of self-awareness such as blindsight and anosognosia. In CD, previous research has focused on the recruitment of motor and emotional brain systems, generally linking symptoms to altered limbic-motor interactions; however, metacognitive function has not been studied to our knowledge. Here we tested ten CD patients and ten age-gender matched controls during a visually-guided motor paradigm, previously employed in healthy controls (HC), allowing us to probe for motor awareness and metacognition. Participants had to draw straight trajectories towards a visual target while, unbeknownst to them, deviations were occasionally introduced in the reaching trajectory seen on the screen. Participants then reported both awareness of deviations and confidence in their response. Activity in premotor and cingulate cortex distinguished between conscious and unconscious movement corrections in controls better than patients. Critically, whereas controls engaged the left superior precuneus and middle temporal region during confidence judgments, CD patients recruited bilateral parahippocampal and amygdalo-hippocampal regions instead. These results reveal that distinct brain regions subserve metacognitive monitoring for HC and CD, pointing to different mechanisms and sources of information used to monitor and form confidence judgments of motor performance. While brain systems involved in sensory-motor integration and vision are more engaged in controls, CD patients may preferentially rely on memory and contextual associative processing, possibly accounting for how affect and memories can imbue current motor experience in these patients.
Collapse
Affiliation(s)
- Indrit Bègue
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland; Swiss Center for Affective Studies, University of Geneva, Switzerland; Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland; Geneva Neuroscience Center, University of Geneva, Switzerland.
| | - Rebekah Blakemore
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland
| | - Julian Klug
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland
| | - Yann Cojan
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland
| | - Silvio Galli
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland
| | - Alexandre Berney
- Service of Consultation-Liaison Psychiatry, Lausanne University Hospital, Lausanne, Switzerland
| | - Selma Aybek
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland; Geneva Neuroscience Center, University of Geneva, Switzerland; Neurology Department, Inselspital, Bern University Hospital, Bern, Switzerland
| | - Patrik Vuilleumier
- Laboratory of Neurology and Imaging of Cognition, Department of Fundamental Neurosciences, University of Geneva, Switzerland; Swiss Center for Affective Studies, University of Geneva, Switzerland; Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland; Geneva Neuroscience Center, University of Geneva, Switzerland
| |
Collapse
|
3
|
Piguet C, Cojan Y, Sterpenich V, Desseilles M, Bertschy G, Vuilleumier P. Alterations in neural systems mediating cognitive flexibility and inhibition in mood disorders. Hum Brain Mapp 2016; 37:1335-48. [PMID: 26787138 DOI: 10.1002/hbm.23104] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2015] [Revised: 08/22/2015] [Accepted: 12/18/2015] [Indexed: 01/25/2023] Open
Abstract
Impairment in mental flexibility may be a key component contributing to cardinal cognitive symptoms among mood disorders patients, particularly thought control disorders. Impaired ability to switch from one thought to another might reflect difficulties in either generating new mental states, inhibiting previous states, or both. However, the neural underpinnings of impaired cognitive flexibility in mood disorders remain largely unresolved. We compared a group of mood disorders patients (n = 29) and a group of matched healthy subjects (n = 32) on a novel task-switching paradigm involving happy and sad faces, that allowed us to separate generation of a new mental set (Switch Cost) and inhibition of the previous set during switching (Inhibition Cost), using fMRI. Behavioral data showed a larger Switch Cost in patients relative to controls, but the average Inhibition Cost did not differ between groups. At the neural level, a main effect of group was found with stronger activation of the subgenual cingulate cortex in patients. The larger Switch Cost in patients was reflected by a stronger recruitment of brain regions involved in attention and executive control, including the left intraparietal sulcus, precuneus, left inferior fontal gyrus, and right anterior cingulate. Critically, activity in the subgenual cingulate cortex was not downregulated by inhibition in patients relative to controls. In conclusion, mood disorder patients have exaggerated Switch Cost relative to controls, and this deficit in cognitive flexibility is associated with increased activation of the fronto-parietal attention networks, combined with impaired modulation of the subgenual cingulate cortex when inhibition of previous mental states is needed.
Collapse
Affiliation(s)
- Camille Piguet
- Neuroscience Department, Faculty of Medicine, University of Geneva, Switzerland
| | - Yann Cojan
- Neuroscience Department, Faculty of Medicine, University of Geneva, Switzerland
| | - Virginie Sterpenich
- Neuroscience Department, Faculty of Medicine, University of Geneva, Switzerland
| | - Martin Desseilles
- Neuroscience Department, Faculty of Medicine, University of Geneva, Switzerland.,Cyclotron Research Center, University of Liege, Belgium
| | - Gilles Bertschy
- Department of Psychiatry and Mental Health, Strasbourg University Hospital, University of Strasbourg, INSERMu666, France
| | - Patrik Vuilleumier
- Neuroscience Department, Faculty of Medicine, University of Geneva, Switzerland
| |
Collapse
|